ChemicalBook > CAS DataBase List > LY 267108

LY 267108

Product Name
LY 267108
CAS No.
105882-69-7
Chemical Name
LY 267108
Synonyms
LY 267108;Erythromycin Imp F;Erythromycin impurity 06;NMIWBQUQCOMGHJ-XWVSLMRSSA-N;Erythromycin Ethyl succinate Impurity F;Pseudo erythromycin A enol ether, EvoPure;8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal;Erythromycin Impurity 15(Erythromycin EP Impurity F);Erythromycin Impurit F:(pseudoerythromycin A enol ether);Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
CBNumber
CB71348120
Molecular Formula
C37H65NO12
Formula Weight
715.91
MOL File
105882-69-7.mol
More
Less

LY 267108 Property

Melting point:
127.0-130.0 °C
Boiling point:
810.7±65.0 °C(Predicted)
Density 
1.20±0.1 g/cm3(Predicted)
storage temp. 
−20°C
solubility 
DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
pka
13.45±0.70(Predicted)
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
38874
Product name
Pseudoerythromycin A enol ether
Purity
analytical standard
Packaging
5mg
Price
$639
Updated
2024/03/01
Cayman Chemical
Product number
15508
Product name
Pseudoerythromycin A enol ether
Purity
≥98%
Packaging
1mg
Price
$98
Updated
2024/03/01
Cayman Chemical
Product number
15508
Product name
Pseudoerythromycin A enol ether
Purity
≥98%
Packaging
5mg
Price
$294
Updated
2024/03/01
American Custom Chemicals Corporation
Product number
API0045939
Product name
PSEUDOERYTHROMYCIN A ENOL ETHER
Purity
95.00%
Packaging
5MG
Price
$503.15
Updated
2021/12/16
More
Less

LY 267108 Chemical Properties,Usage,Production

Chemical Properties

White Solid

Uses

Pseudo Erythromycin A Enol Ether (Erythromycin EP Impurity F) is an Erythromycin impurity.

Uses

Erythromycin impurity.

Uses

Pseudoerythromycin A enol ether is a degradation product of erythromycin formed by a complex internal rearrangement of erythromycin A on exposure to neutral to weakly alkaline conditions. The C6–OH forms an internal enol ether with the C9 ketone of erythromycin, while the C11-OH attacks the carbonyl of the lactone to reduce the macrocycle from a 14- to an 11-membered macrolide. Synthetically, pseudoerythromycin A enol ether is prepared by reacting erythromycin enol ether with carbonate. Pseudoerythromycin A enol ether is devoid of antibiotic activity but is an important analytical standard for erythromycin A stability studies.

LY 267108 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

LY 267108 Suppliers

Chemicea Pharmaceuticals Pvt Ltd
Tel
--
Fax
--
Email
sales@chemicea.com
Country
India
ProdList
825
Advantage
58
Anant Pharmaceuticals Pvt. ltd
Tel
--
Fax
--
Email
info@anantlabs.com
Country
India
ProdList
736
Advantage
58
Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
Olympus Chemicals & Fertilizers
Tel
--
Fax
--
Country
India
ProdList
486
Advantage
58
SynZeal Research Pvt Ltd
Tel
--
Fax
--
Email
standards@synzeal.com
Country
India
ProdList
6514
Advantage
58
Equilife Laboratories Private Limited
Tel
--
Fax
--
Country
India
ProdList
47
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58

105882-69-7, LY 267108Related Search:


  • LY 267108
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-Methylbutyl]-2,6,8,10,12-pentaMethyl-9-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
  • 8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
  • NMIWBQUQCOMGHJ-XWVSLMRSSA-N
  • Erythromycin EP Impurity F/(2R,3R,6R,7S,8S,9R,10R)-3-((2R,3R)-2,3-dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6
  • Erythromycin Impurit F:(pseudoerythromycin A enol ether)
  • Erythromycin Impurity 15(Erythromycin EP Impurity F)
  • Erythromycin Ethyl succinate Impurity F
  • 4,13-Dioxabicyclo[8.2.1]tridec-12-en-5-one, 7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,7S,8S,9R,10R)-
  • Erythromycin Imp F
  • Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
  • Erythromycin impurity 06
  • Pseudo erythromycin A enol ether, EvoPure
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D- xylohexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-1(12)-en-5- one
  • 105882-69-7
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
  • Chromatography
  • Drugs&Metabolites
  • Forensic and Veterinary Standards
  • Neat CompoundsAnalytical Standards
  • Pharmacology Standards